|
gptkb:Oncternal_Therapeutics
|
TK216
|
|
gptkb:Oncternal_Therapeutics
|
cirmtuzumab
|
|
gptkb:Amolyt_Pharma
|
eneboparatide (AZP-3601)
|
|
gptkb:Inozyme_Pharma
|
INZ-701
|
|
gptkb:Kezar_Life_Sciences
|
KZR-616
|
|
gptkb:Zentalis_Pharmaceuticals
|
ZN-c3
|
|
gptkb:Zentalis_Pharmaceuticals
|
zanidatamab
|
|
gptkb:NTLA
|
gptkb:NTLA-6001
|
|
gptkb:IO_Biotech
|
IO102-IO103
|
|
gptkb:Olema_Oncology
|
OP-1250
|
|
gptkb:NTLA
|
gptkb:NTLA-5001
|
|
gptkb:Zentalis_Pharmaceuticals
|
ZN-c5
|
|
gptkb:Kezar_Life_Sciences
|
KZR-261
|
|
gptkb:Centrexion_Therapeutics
|
gptkb:CNTX-4975
|
|
gptkb:NTLA
|
gptkb:NTLA-2001
|